• Latest Posts
In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

Opinion 1 Nov 2023

Could this be the start of a new era for PI3K drugs?

Hope for Alzheimer’s patients after Lilly drug results

Lilly boosts obesity portfolio with Versanis Bio acquisition

BioGeneration Ventures closes BGV Fund V at €150M 


FDA approves type 2 diabetes drug for children 10 and older

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline 

Beyond Biotech podcast 10: Endpoint Health, Nevrargenics, Triastek

5 advancements in kidney disease research over the past year

Lilly to develop Confo pain drug

A Relief for Migraines at last? The Biotech race for the Ultimate Cure